With the help of a routine clinical case, we highlighted the difference between two of the best asthma guidelines available at the time regarding therapeutic suggestions for the so-called “third step” for school-age asthmatic children.

We have analyzed the scientific evidence that each of the two guidelines brings to support their position.

Finally, we have motivatedly solved the clinical scenario.

However, the question of disagreement between two guidelines remains unresolved. This can lead to unjustified differences in the management of schoolchildren with persistent asthma.

中文翻译：

---

学龄儿童哮喘药物治疗第三步指南之间的分歧。

在常规临床案例的帮助下，我们强调了当时可用的两个最佳哮喘指南之间的差异，这些指南关于学龄哮喘儿童所谓的“第三步”的治疗建议。

我们分析了这两个指南中的每一个所带来的支持其立场的科学证据。

最后，我们积极地解决了临床场景。

然而，两个指南之间的分歧问题仍未解决。这可能导致在对患有持续性哮喘的学童的管理方面出现不合理的差异。